Preventive and therapeutic moderate aerobic exercise programs convert atherosclerotic plaques into a more stable phenotype

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCARDINOT, Themis M.
dc.contributor.authorLIMA, Thais M.
dc.contributor.authorMORETTI, Ana I. S.
dc.contributor.authorKOIKE, Marcia K.
dc.contributor.authorNUNES, Valeria S.
dc.contributor.authorCAZITA, Patricia M.
dc.contributor.authorKRIEGER, Marta H.
dc.contributor.authorBRUM, Patricia C.
dc.contributor.authorSOUZA, Heraldo P.
dc.date.accessioned2016-07-18T11:40:45Z
dc.date.available2016-07-18T11:40:45Z
dc.date.issued2016
dc.description.abstractThe mechanisms by which exercise affects atherosclerotic plaque stability remain incompletely understood. We evaluated the effects of two training protocols on both atherosclerotic plaque structure and the signaling pathways involved in plaque rupture. Methods: Male low-density lipoprotein (LDL) receptor knockout mice were fed a high-fat, high-cholesterol diet (HFD). One group was subjected to moderate exercise using a treadmill for 14 weeks (preventive protocol). The other group started an exercise regimen after 16 weeks of the HFD (therapeutic group). Atherosclerotic plaques within the aorta were evaluated for lipid and collagen contents, as well as for inflammatory markers. Plasma cholesterol and cytokine levels were also determined. Results: The mice receiving a HFD developed hypercholesterolemia and atherosclerotic plaques within the aorta. The aortas from the animals in the preventive protocol exhibited smaller lipid cores and higher collagen content. These animals also exhibited lower CD40 expression within the plaques. The aortas of the mice in the therapeutic group exhibited higher collagen content, but no differences in either lipid core size or plaque size were noted. No differences in blood pressure, plasma cholesterol, cytokine levels, plaque size or metalloproteinase 9 expression were observed in the trained animals compared with the sedentary animals. Conclusion: Moderate aerobic exercise modified atherosclerotic plaque characteristics and converted the plaques into a more stable phenotype, increasing the collagen content in response to both exercise programs. Furthermore, moderate aerobic exercise reduced the animals' fat content and decreased the activity of the CD40-CD40L signaling pathway in the preventive group.
dc.description.indexMEDLINE
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/01990-9]
dc.identifier.citationLIFE SCIENCES, v.153, p.163-170, 2016
dc.identifier.doi10.1016/j.lfs.2016.04.007
dc.identifier.eissn1879-0631
dc.identifier.issn0024-3205
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/14116
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relation.ispartofLife Sciences
dc.rightsrestrictedAccess
dc.rights.holderCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.subjectAtherosclerosis
dc.subjectAerobic exercise
dc.subjectPlaque stability
dc.subjectHigh fat diet
dc.subject.otherrisk-assessment strategies
dc.subject.otherreceptor knockout mice
dc.subject.otherc-reactive protein
dc.subject.otherhigh-fat diet
dc.subject.otherphysical-activity
dc.subject.otherendurance exercise
dc.subject.othervulnerable patient
dc.subject.otherdeficient mice
dc.subject.otherheart-disease
dc.subject.othercoronary
dc.subject.wosMedicine, Research & Experimental
dc.subject.wosPharmacology & Pharmacy
dc.titlePreventive and therapeutic moderate aerobic exercise programs convert atherosclerotic plaques into a more stable phenotype
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalCARDINOT, Themis M.:Univ Sao Paulo, Fac Med, Emergency Med Dept LIM 51, Sao Paulo, Brazil
hcfmusp.author.externalMORETTI, Ana I. S.:Univ Sao Paulo, Fac Med, Emergency Med Dept LIM 51, Sao Paulo, Brazil
hcfmusp.author.externalKRIEGER, Marta H.:Univ Estadual Campinas, Inst Biol, Dept Physiol & Biophys, Campinas, SP, Brazil
hcfmusp.author.externalBRUM, Patricia C.:Univ Sao Paulo, Sch Phys Educ & Sports, Sao Paulo, Brazil
hcfmusp.citation.scopus6
hcfmusp.contributor.author-fmusphcTHAIS MARTINS DE LIMA
hcfmusp.contributor.author-fmusphcMARCIA KIYOMI KOIKE
hcfmusp.contributor.author-fmusphcVALERIA SUTTI NUNES
hcfmusp.contributor.author-fmusphcPATRICIA MIRALDA CAZITA
hcfmusp.contributor.author-fmusphcHERALDO POSSOLO DE SOUZA
hcfmusp.description.beginpage163
hcfmusp.description.endpage170
hcfmusp.description.volume153
hcfmusp.origemWOS
hcfmusp.origem.pubmed27074350
hcfmusp.origem.scopus2-s2.0-84966397579
hcfmusp.origem.wosWOS:000376484500019
hcfmusp.publisher.cityOXFORD
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceMatsumoto Y, 2010, CIRCULATION, V121, P759, DOI 10.1161/CIRCULATIONAHA.109.892224
hcfmusp.relation.referenceWannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8
hcfmusp.relation.referenceWang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011
hcfmusp.relation.referenceSouza HP, 2009, CLIN SCI, V116, P423, DOI 10.1042/CS20080155
hcfmusp.relation.referenceSchwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20
hcfmusp.relation.referenceKelly CR, 2014, AM J CARDIOL, V114, P376, DOI 10.1016/j.amjcard.2014.04.048
hcfmusp.relation.referenceYi CX, 2012, PHYSIOL BEHAV, V106, P485, DOI 10.1016/j.physbeh.2012.03.021
hcfmusp.relation.referenceNapoli C, 2004, P NATL ACAD SCI USA, V101, P8797, DOI 10.1073/pnas.0402734101
hcfmusp.relation.referenceNaghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
hcfmusp.relation.referenceThompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77
hcfmusp.relation.referenceGarcia JAD, 2008, J CARDIOVASC PHARM, V51, P78, DOI 10.1097/FJC.0b013e31815c39d4
hcfmusp.relation.referenceMoreira ELG, 2013, NEUROSCI LETT, V541, P193, DOI 10.1016/j.neulet.2013.02.043
hcfmusp.relation.referenceNaghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9
hcfmusp.relation.referenceSzostak J, 2011, CLIN SCI, V121, P91, DOI 10.1042/CS20100520
hcfmusp.relation.referenceSchonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458
hcfmusp.relation.referencePAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763
hcfmusp.relation.referenceRekhter MD, 2002, CARDIOVASC RES, V54, P36, DOI 10.1016/S0008-6363(01)00537-5
hcfmusp.relation.referenceBaar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334
hcfmusp.relation.referenceTian J, 2014, J AM COLL CARDIOL, V64, P672, DOI 10.1016/j.jacc.2014.05.052
hcfmusp.relation.referenceShon SM, 2011, ATHEROSCLEROSIS, V216, P67, DOI 10.1016/j.atherosclerosis.2011.01.036
hcfmusp.relation.referenceBentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721
hcfmusp.relation.referenceMedeiros C, 2011, J CELL PHYSIOL, V226, P666, DOI 10.1002/jcp.22387
hcfmusp.relation.referenceMeilhac O, 2001, ARTERIOSCL THROM VAS, V21, P1681, DOI 10.1161/hq1001.097106
hcfmusp.relation.referenceTeodoro BG, 2012, J ATHEROSCLER THROMB, V19, P904
hcfmusp.relation.referenceOtsuka F, 2014, NAT REV CARDIOL, V11, P379, DOI 10.1038/nrcardio.2014.62
hcfmusp.relation.referenceKasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077
hcfmusp.relation.referenceGALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619
hcfmusp.relation.referenceShimada K, 2007, CIRC J, V71, P1147, DOI 10.1253/circj.71.1147
hcfmusp.relation.referenceDAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801
hcfmusp.relation.referenceNiebauer J, 2003, AM J PHYSIOL-HEART C, V285, pH535, DOI 10.1152/ajpheart.00360.2001
hcfmusp.relation.referenceOkabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019
hcfmusp.relation.referenceLeon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021
hcfmusp.relation.referencePetersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004
hcfmusp.relation.referenceRUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0
hcfmusp.relation.referenceTouati S, 2011, MED SCI SPORT EXER, V43, P398, DOI 10.1249/MSS.0b013e3181eeb12d
hcfmusp.relation.referenceMatsumoto A, 2013, INT J CARDIOL, V167, P1282, DOI 10.1016/j.ijcard.2012.03.172
hcfmusp.relation.referenceLangbein H, 2015, ATHEROSCLEROSIS SUPP, V18, P59, DOI 10.1016/j.atherosclerosissup.2015.02.010
hcfmusp.relation.referenceBoden WE, 2014, AM J MED, V127, P905, DOI 10.1016/j.amjmed.2014.05.007
hcfmusp.relation.referenceGLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204
hcfmusp.relation.referenceHammett C. J., 2006, AM HEART J, V151, p[e367, e316]
hcfmusp.relation.referenceHammett CJ, 2006, AM HEART J, V151, P367
hcfmusp.relation.referenceLeon A. S., 2001, MED SCI SPORTS EXERC, V33, pS528
hcfmusp.relation.referenceLibby P, 2003, AM J CARDIOL, V91, P4, DOI 10.1016/S0002-9149(02)03267-8
hcfmusp.relation.referenceMoustardas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108240
hcfmusp.relation.referenceNie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097009
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication114c9a26-7d28-408f-9a24-85f35bed67e1
relation.isAuthorOfPublicationd793372b-9a90-4a06-84bc-ae958341a820
relation.isAuthorOfPublication53de8332-95fd-4c89-a0e5-61aa19ef33cb
relation.isAuthorOfPublication4e786449-8885-4a2b-b40f-6fe985e8a802
relation.isAuthorOfPublication9a561822-4752-4c79-87c4-0b9ca5a67a36
relation.isAuthorOfPublication.latestForDiscovery114c9a26-7d28-408f-9a24-85f35bed67e1
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_CARDINOT_Preventive_and_therapeutic_moderate_aerobic_exercise_programs_convert_2016.PDF
Tamanho:
1.35 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)